Core Viewpoint - Longxin Zhongke aims for significant revenue growth in 2025 after two consecutive years of decline, with ambitious targets set in its stock incentive plan [2][4] Revenue and Financial Performance - Longxin Zhongke's revenue for 2024 is projected at 5.04 billion yuan, a slight decline of 0.28% year-on-year [5] - The company reported a revenue of 2.44 billion yuan in the first half of 2025, reflecting a year-on-year increase of 10.90% [7] - To meet the revenue trigger value for 2025, the company needs to achieve 6.25 billion yuan, with a target of 6.55 billion yuan [5] - Cumulatively, the company has incurred a net loss of 12.48 billion yuan over the past two and a half years [11] Stock Incentive Plan - The stock incentive plan includes granting 530,900 restricted shares, representing 0.13% of the company's total share capital [3][4] - The exercise price for the restricted shares is set at 79.03 yuan per share, approximately 50% of the closing price on the announcement date [4] - The performance assessment for the incentive plan is based on revenue growth, with a trigger value of 24% and a target of 30% for 2025 [4][5] Research and Development Investment - Despite ongoing losses, Longxin Zhongke has maintained high R&D expenditures, totaling 10.89 billion yuan over the past two and a half years [12][14] - R&D expenses for 2023 and 2024 were 4.25 billion yuan and 4.30 billion yuan, respectively, with year-on-year increases of 35.68% and 1.33% [13][14] - The company plans to shift focus from R&D to market engagement from 2025 to 2027, aiming to improve product competitiveness and reduce reliance on policy-driven markets [14]

Core Viewpoint - Longxin Zhongke (龙芯中科) aims for significant revenue growth in 2025 after two consecutive years of decline, with ambitious targets set in its stock incentive plan [1][3][4] Revenue and Financial Performance - Longxin Zhongke's revenue for 2024 is projected at 5.04 billion yuan, a slight decline of 0.28% year-on-year [4] - The company reported a revenue of 2.44 billion yuan in the first half of 2025, reflecting a year-on-year increase of 10.90% [6] - To meet the revenue trigger value for 2025, the company needs to achieve 3.81 billion yuan in the second half, a 34% increase from 2.84 billion yuan in the same period last year [1][7] - Cumulative net losses over the past two and a half years have reached 12.48 billion yuan, with significant losses reported in 2023 and 2024 [10] Stock Incentive Plan - The stock incentive plan includes a target of 53.09 million restricted shares, representing 0.13% of the company's total share capital [2] - The grant price for the restricted shares is set at 79.03 yuan per share, approximately 50% of the closing price on the announcement date [2] - The performance assessment for the incentive plan is based on revenue growth, with a 24% trigger value and a 30% target for 2025 [3][4] Research and Development Investment - Despite ongoing losses, Longxin Zhongke has maintained high R&D expenditures, with 4.25 billion yuan and 4.30 billion yuan spent in 2023 and 2024, respectively [11][12] - Cumulative R&D expenses over the past two and a half years amount to 10.89 billion yuan [13] - The company plans to shift focus from R&D to market engagement from 2025 to 2027, aiming to improve product competitiveness and reduce reliance on policy-driven markets [13]